Bandingkan Harga & Kinerja Catur Sentosa Adiprana Tbk. (CSAP) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Catur Sentosa Adiprana Tbk. dan UBC Medical Indonesia Tbk.: Catur Sentosa Adiprana Tbk. diperdagangkan di Rp284 (kapitalisasi pasar 1,61 T, volume 24 jam 23 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Catur Sentosa Adiprana Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 23 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CSAP | LABS | |
|---|---|---|
Kapitalisasi Pasar | 1,61 T | 584,6 M |
Volume | 23 rb | 817,3 rb |
Lot | 230 | 8,17 rb |
Perputaran | 6,57 jt | 120,01 jt |
Harga Rata-rata | 285,67 | 146,84 |
Nilai Transaksi | 6,57 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 282 | 146 |
Volume Ekuilibrium Indikatif | 3 | 59 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Catur Sentosa Adiprana Tbk.
Catur Sentosa Adiprana Tbk (the company) was established on 31 Dec 1983 based on Notaries Deed No. 93 and the deed of establishment was approved by the the Ministry of Justice dated Sep 18, 1983. Based on the Company’s stockholders’ circular resolution dated June 6, 2007, the stockholders approved the change in the legal status of the Company from a Limited Liability Company “Perseroan Terbatas” with Foreign Capital Investments facility to a Limited Liability Company “Perseroan Terbatas” with Non-Foreign Capital Investments facility/Domestic Capital Investments, including the revocation and/or cancellation of every existing agreement of the Company related to Foreign Capital Investments.
Selengkapnya di halaman CSAP →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
